Concepedia

Efficacy and safety of 24 weeks treatment with oral TLR8 agonist, selgantolimod, in virally-suppressed adult patients with chronic hepatitis B: a phase 2 study

Edward Gane, P. Rod Dunbar, Anna E. S. Brooks, Yang Zhao, Susanna K. Tan, Audrey Lau, Jenny Yang, Anuj Gaggar, Mani Subramanian, Shyamasundaran Kottilil,

Journal of Hepatology · 2020 · 31 citations · 0 references

Concepts

PharmacyPharmacologyPharmacotherapyHepatitis PharmacotherapyHepatologyImmunopharmacologyAntiviral TherapyChronic Liver DiseaseInterferon-based TherapyTreatment DurationViral HepatitisViral Hepatitis TreatmentChronic Viral HepatitisHepatitis B TherapyHepatitis B Virus Management